I would never want to do a commercial unless I could do it on my own terms, unless it could be genuinely funny and creative.” ...

Accord BioPharma Inc., the U.S. specialty division of Intas Pharmaceuticals Ltd., has reached an exclusive commercialization and license agreement with Bio-Thera Solutions for BAT2506, a biosimilar ...

NASCAR driver Ross Chastain is featured in a Super Bowl commercial this year thanks to Busch Light. (Busch Light) ...

Former Miami-based World Bank leader laments as the Trump administration pauses foreign assistance programs | Opinion ...

Chinas top economic planning agency announced plans to scale back subsidies for renewable energy projects after a record ...

RALEIGH, NC, USA I 10, 2025 I Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas ...

Mexico has repealed import restrictions on genetically modified corn for human, livestock and industrial uses following a US ...

BPER's bid for Banca Popolare di Sondrio was not previously agreed, a person close to the Italian bank said on Friday, after it became the latest takeover target in a series of bids rocking the ...

Canaccord lowered the firm’s price target on Neurocrine (NBIX) to $163 from $172 and keeps a Buy rating on the shares. The firm said management ...

Mexico's government has repealed previous restrictions on genetically-modified (GM) corn for human use, as well for livestock ...

The NSW Government has flagged the creation of a think tank involving local councils to drive the revival of Parramatta Road ...

CVRx (NASDAQ:CVRX – Free Report) had its price objective hoisted by Canaccord Genuity Group from $22.00 to $23.00 in a research report report published on Wednesday morning,Benzinga reports. They ...